Prenatal and early life exposure to air pollution and lung function development aged 8-24 years: The ALSPAC study

Katie Eminson1, Yingxin Chen2, Raquel Granell3

  • 1Centre for Environmental Health and Sustainability, University of Leicester, Leicester, United Kingdom; National Institute for Health Research (NIHR) Leicester Biomedical Research Centre (BRC), Leicester General Hospital, Leicester, United Kingdom.

Environmental Research
|March 18, 2026
PubMed

Insights

Prenatal and early-life exposure to air pollution, including PM10 and NO2, was linked to reduced lung function growth in children up to age 24. These effects were most pronounced during adolescence.

Area of Science:

  • Environmental Health
  • Pediatric Pulmonology
  • Epidemiology

Background:

  • Limited evidence exists on air pollution's impact on childhood lung function growth.
  • Previous studies show associations between early air pollution and lung function, but not long-term growth trajectories.

Purpose of the Study:

  • To assess the association between air pollution exposure during pregnancy and early life and lung function growth from ages 8 to 24.
  • Investigate the impact of specific air pollutants (PM10 and NO2) on lung function development.

Main Methods:

  • Longitudinal study of approximately 5200 children from the ALSPAC UK birth cohort.
  • Used mixed-effects linear models to analyze lung function data (FEV1, FVC, FEF25-75, FEV1/FVC) at ages 8, 15, and 24 years.
  • Adjusted for various covariates including socioeconomic status, smoking, and BMI.

Main Results:

  • Elevated exposure to PM10 (road and other) and NO2 during pregnancy and early life was associated with small reductions in annual lung function growth z-scores.
  • The impact on lung function growth was more substantial between ages 8 and 15 years compared to growth up to 24 years.
  • A 1-unit increase in road PM10 exposure was linked to a -0.0122 decrease in FEV1 z-score growth annually.

Conclusions:

  • Higher exposure to PM10 and NO2 during critical developmental periods may negatively affect lung function development.
  • The greatest impact on lung function growth appears during adolescence, a period of rapid lung development.
  • Findings extend previous research by tracking lung function growth to age 24 and including mid-expiratory flow measures.
Abstract

Related Concept Videos

Chronic Obstructive Pulmonary Disease-I: Introduction01:20

Chronic Obstructive Pulmonary Disease-I: Introduction

Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
4.1K
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
5.0K
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
2.2K
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics01:23

Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics

Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla.  Benzonatate operates peripherally within the respiratory tract by...
1.6K
Breathing01:05

Breathing

The process of breathing, inhaling and exhaling, involves the coordinated movement of the chest wall, the lungs, and the muscles that move them. Two muscle groups with important roles in breathing are the diaphragm, located directly below the lungs, and the intercostal muscles, which lie between the ribs. When the diaphragm contracts, it moves downward, increasing the volume of the thoracic cavity and creating more room for the lungs to expand. When the intercostal muscles contract, the ribs...
66.2K
Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
3.7K